Archived Story
Top News
Moderna's mRNA vaccine showed promising results in phase 1 trial, generated robust immune reaction, and it's dose dependent. Phase 2 to start soon with 600 people joining, and phase 3 in July with thousands of people
The company said its preliminary test in 8 healthy volunteers was safe. It is on an accelerated timetable to begin a larger human trial soon
NIH launches a 2000-patient clinical trial to test if hydroxychloroquine and azithromycin can prevent COVID-19 patients from hospitalization or death
Study enrolling adults with mild to moderate COVID-19 in the United States.
Abbott's ID Now fast Covid-19 test, claimed to show results within 5 to 13 minutes, used daily by White House and many hospitals, was found to miss infection for up to 48% (false negative). FDA issues warning of inaccuracy of this test
A study found that the Abbott ID Now machine was less accurate when it processed short, dry swabs
FDA impose tighter rules for Covid-19 antibody blood tests after hundreds of unproven and potentially fraudulent tests flooded US market amid the pandemic
At least 160 antibody tests for Covid-19 entered the U.S. without prior FDA scrutiny
Google & Apple to ban location tracking in their contact tracing apps, which may impact the effectiveness of those vital systems to public health during disease outbreaks and pandemic
The technology giants have laid out new rules for those using their upcoming exposure notification system
Japan to approve remdesivir in days following FDA's emergency approval for treating Covid-19. Tokyo asks Washington for steady supply while EMA starts reviewing to accelerate approval in Europe
Treatment could be available as early as mid-May
"The Manhattan Project" of Covid-19 era - a group of prominent scientists and billionaires working behind the scenes sharing findings with the White House, pushing for solutions to end the pandemic
They are working to cull the world’s most promising research on the pandemic, passing on their findings to policy makers and the White House
Japan soon to approve remdesivir, Gilead's COVID-19 drug, in May, according to Prime Minister Shinzo Abe. If so, Japan will be the first country to approve this drug for treating COVID-19 patients
Antiviral drug will receive fast-track status if certified by another nation
As countries and states re-open economy, race of Covid-19 vaccine is on. France, Germany, and WHO to launch a $8B push on vaccine while US opt out. Merck to jump in by collaborating with Seattle-based Institute for Systems Biology
Other countries might not be quick to share. Time to speed up trials and ramp up manufacturing scale
Jobs
-
: The future of medicine is happening at Pfizer
-
: Bold, Relentless, Curious, and Collaborative
-
: Invent. Impact. Inspire.
-
: We're changing the trajectory of human health
-
: Inspired cell solutions
-
: Join the Revolution
-
: Pioneer transformative, gene-based medicines
-
: Driven by a passion to invent
-
: every position helps our company excel
-
: accelerate the discovery of new & better medicines
-
: Come join the Beam team
-
: exciting, rapidly expanding, ambitious
-
: help us invent the future of pharma research
-
: grow beyond
-
: create the next revolution in cancer treatment
Latest News
Remdesivir alone is not enough, researchers conclude in first major Covid-19 trial of the drug
22 May 2020, 9:01 PM, Maggie Fox, CNN
Remdesivir for the Treatment of Covid-19 — Preliminary Report
22 May 2020, 8:56 PM, John Beigel, New England Journal of Medicine (NEJM)
Covid-19 study details benefits of treatment with remdesivir, and also its limitations
22 May 2020, 8:54 PM, Matthew Herper, STAT
AstraZeneca receives $1 billion in US funding for Oxford University coronavirus vaccine
21 May 2020, 1:34 PM, Vicky McKeever, CNBC
Moderna's COVID-19 Vaccine Shows Promise, Generating Positive Immune Responses in an Early Study
18 May 2020, 4:33 PM, Alice Park, TIME (US magazine)
Coronavirus Vaccine Trial by Moderna Shows Promising Early Results
18 May 2020, 4:30 PM, Denise Grady, New York Times
Criticism of the Oxford Coronavirus Vaccine
18 May 2020, 2:05 PM, Derek Lowe, Science Translational Medicine
What African Nations Are Teaching the West About Fighting the Coronavirus
15 May 2020, 10:52 PM, Jina Moore, The New Yorker
NIH begins clinical trial of hydroxychloroquine and azithromycin to treat COVID-19
15 May 2020, 1:01 PM, Christopher Carbone, Fox News
FDA Cautions About Accuracy Of Widely Used Abbott Coronavirus Test
15 May 2020, 3:29 AM, Joe Neel, NPR - National Public Radio
Coronavirus: Children affected by rare Kawasaki-like disease
14 May 2020, 3:59 PM, Staff Writer, BBC
Twin antibodies show neutralizing activity against SARS-CoV-2
14 May 2020, 2:56 PM, VICTORIA CORLESS, Advanced Science News
NIH begins clinical trial of hydroxychloroquine and azithromycin to treat COVID-19
14 May 2020, 12:56 PM, Staff Writer, National Institutes of Health (NIH) - US
Coronavirus (COVID-19) Update: FDA Informs Public About Possible Accuracy Concerns with Abbott ID NOW Point-of-Care Test
14 May 2020, 3:34 AM, US FDA, PR Newswire
New Inflammatory Condition in Children Probably Linked to Coronavirus, Study Finds
13 May 2020, 4:39 PM, Pam Belluck, New York Times
What we know about the new Covid-19-linked illness in children
13 May 2020, 4:25 PM, Katherine Harmon Courage, VOX
Dr Liz Whittaker on rare inflammatory syndrome linked to Covid-19
13 May 2020, 4:15 PM, Matt Frei, Channel 4 News -London UK
Kawasaki-like disease: emerging complication during the COVID-19 pandemic
13 May 2020, 4:02 PM, Elizabeth Whittaker, The Lancet
A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2
13 May 2020, 2:53 PM, Shihua Li, Science
SARS-CoV-2 Spike Foiled by Antibody Duo
13 May 2020, 2:51 PM, Staff Writer, Genetic Engineering & Biotechnology News